Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis.

Rohner, Andreas

Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. [electronic resource] - Leukemia research Oct 2007 - 1393-402 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0145-2126

10.1016/j.leukres.2007.02.020 doi


Acute Disease
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Azacitidine--administration & dosage
Bryostatins--administration & dosage
Cell Differentiation
Cell Line, Tumor
Cholecalciferol--administration & dosage
Cytotoxicity, Immunologic
Decitabine
Flow Cytometry
GPI-Linked Proteins
Humans
Hydroxamic Acids--administration & dosage
Intercellular Signaling Peptides and Proteins--metabolism
Killer Cells, Natural--immunology
Leukemia, Myeloid--immunology
Reverse Transcriptase Polymerase Chain Reaction
Tretinoin--administration & dosage
Up-Regulation